About BIO-TECHNE Corp
Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through three segments: Biotechnology, Clinical Controls and Protein Platforms. The Biotechnology segment develops, manufactures and sells biotechnology research and diagnostic products, such as cytokines, growth factors, immunoassays, antibodies and related reagents, across the world. The Clinical Controls segment develops and manufactures controls, calibrators, immunoassays and other reagents for the global clinical market. The Protein Platforms segment develops and commercializes systems and consumables for protein analysis. It markets immunoassays on different testing platforms, including microtiter-plate based kits sold under the trade name Quantikine, and immunoassays based on planar spotted surfaces and microfluidic-based multiplex immunoassays on automated testing platform.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Biotechnology
- Sub-Industry: Life Sciences Tools & Services
- Exchange: NASDAQ
- Symbol: TECH
- CUSIP: 87837710
- Previous Close: $106.34
- 50 Day Moving Average: $101.99
- 200 Day Moving Average: $105.14
- 52-Week Range: $37,311,000.00 - $85.34
- Trailing P/E Ratio: 50.81
- Foreward P/E Ratio: 27.19
- P/E Growth: 2.88
- Market Cap: $3.98B
- Outstanding Shares: 37,311,000
- Beta: 0.73
- Net Margins: 14.87%
- Return on Equity: 13.95%
- Return on Assets: 9.28%
Companies Related to BIO-TECHNE Corp:
- Debt-to-Equity Ratio: 0.39%
- Current Ratio: 2.44%
- Quick Ratio: 1.90%
What is BIO-TECHNE Corp's stock symbol?
BIO-TECHNE Corp trades on the NASDAQ under the ticker symbol "TECH."
How often does BIO-TECHNE Corp pay dividends? What is the dividend yield for BIO-TECHNE Corp?
BIO-TECHNE Corp declared a quarterly dividend on Tuesday, February 7th. Shareholders of record on Friday, February 17th will be given a dividend of $0.32 per share on Friday, March 3rd. This represents a $1.28 annualized dividend and a yield of 1.20%. The ex-dividend date is Wednesday, February 15th.
Where is BIO-TECHNE Corp's stock going? Where will BIO-TECHNE Corp's stock price be in 2017?
5 analysts have issued 12-month price objectives for BIO-TECHNE Corp's stock. Their predictions range from $115.00 to $122.00. On average, they anticipate BIO-TECHNE Corp's stock price to reach $117.20 in the next twelve months.
When will BIO-TECHNE Corp announce their earnings?
BIO-TECHNE Corp is scheduled to release their next quarterly earnings announcement on Monday, April, 24th 2017.
Who owns BIO-TECHNE Corp stock?
BIO-TECHNE Corp's stock is owned by a number of of retail and institutional investors. Top institutional investors include Brown Capital Management LLC (6.14%), Atlanta Capital Management Co. L L C (3.29%), Janus Capital Management LLC (2.69%), State Street Corp (2.59%), Royce & Associates LP (2.08%) and Columbia Wanger Asset Management LLC (1.58%). Company insiders that own BIO-TECHNE Corp stock include Charles A Dinarello, John L Higgins, Karen A Holbrook, Kevin S Gould, Randolph C Steer, Robert V Baumgartner and Roger C Lucas.
Who sold BIO-TECHNE Corp stock? Who is selling BIO-TECHNE Corp stock?
BIO-TECHNE Corp's stock was sold by a variety of institutional investors in the last quarter, including Highland Capital Management LP, Sandler Capital Management, State Street Corp, Columbia Wanger Asset Management LLC, Janus Capital Management LLC, Denver Investment Advisors LLC, Turner Investments LLC and Credit Agricole S A. Company insiders that have sold BIO-TECHNE Corp stock in the last year include Charles A Dinarello, John L Higgins, Karen A Holbrook, Kevin S Gould, Robert V Baumgartner and Roger C Lucas.
Who bought BIO-TECHNE Corp stock? Who is buying BIO-TECHNE Corp stock?
BIO-TECHNE Corp's stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Fred Alger Management Inc., Renaissance Technologies LLC, Royce & Associates LP, Brown Capital Management LLC, Guggenheim Capital LLC, First Light Asset Management LLC and Capstone Investment Advisors LLC.
How do I buy BIO-TECHNE Corp stock?
Shares of BIO-TECHNE Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of BIO-TECHNE Corp stock cost?
One share of BIO-TECHNE Corp stock can currently be purchased for approximately $106.59.